Heart failure. Can vasopressin antagonists improve the prognosis?
MMW Fortschritte der Medizin 145(48): 10
2003
ISSN/ISBN: 1438-3276 PMID: 14724989 Document Number: 566574
Document emailed within 1 workday
Related Documents
2008: Chronic heart failure: sports improve the prognosis MMW Fortschritte der Medizin 150(47): 14Jard, S.; Gaillard, R.C.; Guillon, G.; Marie, J.; Schoenenberg, P.; Muller, A.F.; Manning, M.; Sawyer, W.H. 1986: Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis Molecular Pharmacology 30(2): 171-177
Jard, S. 1988: Mechanisms of action of vasopressin and vasopressin antagonists Kidney International. Suppl 26: S38-S42
Hammond, J.J. 1980: Failure of therapy to improve prognosis in elderly males with hypertension Medical Journal of Australia 2(8): 460-461
Barbieri, L.; Mestroni, L.; Camerini, F. 1988: Calcium antagonists in congestive heart failure Giornale Italiano di Cardiologia 18(11): 989-996
Aursnes, I. 2004: Do calcium antagonists prevent heart failure in hypertension? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 124(1): 42-43
Pereirinha, A.; Amaro, M.J.; Lopes, M.G.; de Pádua, F. 1993: Calcium antagonists in the treatment of congestive heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 12(Suppl 4): 47-51; 9
Zharov, E.I.; Vertkin, A.L.; Prokhorovich, E.A.; Adib, B.M. 1987: Calcium antagonists in the treatment of congestive heart failure Klinicheskaia Meditsina 65(2): 20-27
Bundkirchen, A.; Brixius, K.; Schwinger, R.H.G. 2004: Beta-adrenoceptor antagonists in the treatment of chronic heart failure Die Pharmazie 59(2): 83-92
Katayama, N.; Horiuchi, K.; Nakao, K.; Kasanuki, H.; Honda, T. 2005: Does percutaneous coronary intervention in non-culprit vessels improve the prognosis of acute myocardial infarction complicated by pump failure? Journal of Cardiology 46(1): 1-8
Edner, M.; Lund, L.H. 2013: Renin-angiotensin system antagonists associated with reduced [corrected] mortality in diastolic heart failure Lakartidningen 110(7): 331
Rodrigues, R.A.; Dias, P.; Pereira, M.; Castro, A.; Queirós, M.C.; Monteiro, E.; Araújo, V.; Bettencourt, P.; Ferreira, A. 2001: Echocardiographic patterns and prognosis in heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 20(12): 1241-1246
Nicod, P.; Goy, J.; Waeber, B.; Bussien, J.P.; Turini, G.A.; Nussberger, J.; Hofbauer, K.G.; Brunner, H.R. 1985: Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure Schweizerische Medizinische Wochenschrift 115(50): 1823-1825
Scorsin, M.; Hagege, A.A.; Dolizy, I.; Marotte, F.; Mirochnik, N.; Copin, H.; Barnoux, M.; le Bert, M.; Samuel, J.L.; Rappaport, L.; Menasché, P. 1998: Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation 98(19): II151
Boccanelli, A.; Pontillo, D.; Carboni, G.P.; Primiano, O.; Capodiferro, R.; Pompili, A.; Zachara, E.; Prati, P.L. 1988: Parameters indicative of the prognosis and efficacy of therapy in heart failure Giornale Italiano di Cardiologia 18(12): 1059-1064
Liu, F.G. 1989: Risk factors and prognosis of ventricular arrhythmia during heart failure Zhonghua Xin Xue Guan Bing Za Zhi 17(3): 165-166
Gavazzi, A. 1999: Improvement of HF: initiative to increase awareness and improve the management of patients with heart failure in Europe Giornale Italiano di Cardiologia 29(12): 1445-1451
Bischoff, A. 2002: Essential basics in therapy of heart failure. Without diuretics the prognosis is poor MMW Fortschritte der Medizin 144(29-30): 6-8
Thibonnier, M. 1988: Use of vasopressin antagonists in human diseases Kidney International. Suppl 26: S48-S51
Hughes, C.V.; Wong, M.; Johnson, G.; Cohn, J.N. 1993: Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies Group Circulation 87(6): Vi111-Vi117